Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess

NCT01422759 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Hyperandrogenemia
Polycystic Ovary Syndrome

Interventions

DRUG: Spironolactone

Sponsor

University of Virginia